← Back to patent-cliff list
达格列净丙二醇一水化物/盐酸沙格列汀
Tier C — Watch / tradeDapagliflozin Propanediol Monohydrate/Saxagliptin Hydrochloride
阿斯利康
Originator
2016
First approval
-
Expiry (public)
No sales data
Peak sales
化学药
Type
Targets：SGLT2、DPP4
Brand：Qtern
Indications (approved)：二型糖尿病
Regional status
US
撤市
EU
批准上市
2016-07-15
China
-
Japan
-
Synthetic routes & intermediates
Routes not yet onboarded — the daily pipeline enriches by priority (approved small molecules first); this page updates automatically.
Frequently asked questions
What are the approved indications of Dapagliflozin Propanediol Monohydrate/Saxagliptin Hydrochloride?
Approved indications include: 二型糖尿病.
When does the Dapagliflozin Propanediol Monohydrate/Saxagliptin Hydrochloride patent expire?
No public expiry year is available for Dapagliflozin Propanediol Monohydrate/Saxagliptin Hydrochloride yet; this page updates once verified.
How do I get a quote for Dapagliflozin Propanediol Monohydrate/Saxagliptin Hydrochloride intermediates?
Open the CAS profile of the target intermediate from this page, or submit an RFQ directly — the CAS enters the matching flow automatically and the supply network responds with quotes.
Source: cross-verified data (structured fields only) · 2026-09-24